Basic info
Industry
biotechnology research
Sectors
Biotechnology
Treg
Oncology
Pharmaceutical
Cell Therapy
Health Care
Immunology
Cancer therapy
Therapeutics
T cell biology
Medical
Molecular biology
Life Science
Date founded
2015
Funding rounds raised
Total raised
$125M
from 10 investors over 10 rounds
T
TCR² Therapeutics Inc. raised $125M on March 21, 2018
Investors: Syno Capital, Redmile Group, Hillhouse Capital Management, UBS Asset Management, Mirae Asset MAPS Global Investments Co., Ltd, MPM Capital, Haitong International Securities Group Limited and Sirona Capital
T
TCR² Therapeutics Inc. raised $45M on December 8, 2016
Investors: UBS Asset Management and MPM Capital